Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-29, Stock:NVS, The news for the past five days is as follows:
2018-10-22: NEWS1: Novartis Announces Full Data From LIBERTY Study Of Aimovig.NEWS2: Novartis Announces Full Data From LIBERTY Study Of Aimovig.NEWS3: Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates.NEWS4: Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates.NEWS5: How Novartis’s Innovative Medicines Business Performed in Q3.NEWS6: Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates.NEWS7: How Novartis’s Business Segments Performed in the Third Quarter.NEWS8: Novartis Reports Third-Quarter Revenue Growth.NEWS9: BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?.NEWS10: BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?.NEWS11: BIIB, ALKS Q3 Earnings Due on Oct 23: What&apos;s in Store?.NEWS12: This tiny biotech spun a quick $2 billion from $12 million.NEWS13: Novartis Reveals New Data Analysis Of COMBI-AD Study Of Tafinlar With Mekinist.NEWS14: Novartis Reveals New Data Analysis Of COMBI-AD Study Of Tafinlar With Mekinist.
2018-10-23: NEWS1: How Is Novartis Valued?.NEWS2: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS3: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS4: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS5: How Novartis’s Alcon Performed in Third Quarter.NEWS6: How Novartis’s Sandoz Performed in the Third Quarter.NEWS7: Why Aduro Biotech Crashed 29.5% Today.NEWS8: Why Aduro Biotech Crashed 29.5% Today.
2018-10-24: NEWS1: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS2: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS3: A Performance Overview of Johnson & Johnson.NEWS4: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS5: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS6: What Analysts Recommend for Novartis after Q3 Earnings.
2018-10-25: NEWS1: Bulls bet this financial name is set to bounce. Plus, the....NEWS2: How Is Johnson & Johnson’s Vision Care Business Positioned?.
2018-10-26: NEWS1: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS2: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS3: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS4: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS5: Celgene’s Revlimid and Pomalyst Saw Solid Q3 Growth.NEWS6: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS7: Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View.NEWS8: Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View.NEWS9: The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default.NEWS10: Novartis Gets EC Approval For Cosentyx Label Update In Europe - Quick Facts.NEWS11: Novartis Gets EC Approval For Cosentyx Label Update In Europe - Quick Facts.

Answer: Rise